Sex and gender in inflammatory bowel disease outcomes and research
Vibeke Andersen,Jessica Pingel,Heidi Lynge Søfelt,Zainab Hikmat,Mads Johansson,Vera Slyk Pedersen,Benthe Bertelsen,Anne Carlsson,Marie Lindh,Edda Svavarsdóttir,Dirk Repsilber,Maiken Thyregod Joergensen,Robin Christensen,Anja Fejrskov,Johannes David Füchtbauer,Jens Kjeldsen,Michael Dam Jensen,Claus Aalykke,Martin Rejler,Marte Lie Høivik,Loa Davidsdottir,Marie Carlson,Jonas Halfvarson,Heidi Holt Zachariassen,Liv Baisner Petersen,Eva Sophia Myers
DOI: https://doi.org/10.1016/S2468-1253(24)00159-6
Abstract:Extensive patient heterogeneity is a challenge in the management of inflammatory bowel disease (IBD). Sex and gender, as well as the interaction of sex and gender with other social identities, referred to as intersectionality, contribute to this heterogeneity and might affect IBD outcomes. An interdisciplinary team of clinicians, researchers, patients, and sex and gender experts reviewed current literature on the effect of sex and gender dimensions on IBD outcomes. The team also investigated the role that stakeholders have in advancing sex-based and gender-based IBD knowledge, as comprehensive studies are scarce. Acknowledging and integrating sex and gender into the organisation and content of research (eg, study design, participant recruitment, data analysis, data interpretation, data dissemination, and impact evaluation) could enhance the validity, relevance, and applicability of research. Such gendered innovation has potential for advancing personalised medicine and improving the quality of life for people with IBD.